1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 507 High dimensional flow cytometry analysis in newly diagnosed acute myeloid leukemia predicts patients outcomes. (9th November 2020) Authors: Mazziotta, Francesco; Mukhopadhyay, Rupkatha; Knaus, Hanna A; Chowdhury, Anish; Blackford, Amanda; Gojo, Ivana; Luznik, Leo Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome. (8th July 2014) Authors: Kirschbaum, Mark; Gojo, Ivana; Goldberg, Stuart L.; Bredeson, Christopher; Kujawski, Lisa A.; Yang, Allen; Marks, Peter; Frankel, Paul; Sun, Xing; Tosolini, Alessandra; Eid, Joseph E.; Lubiniecki, Gregory M.; Issa, Jean‐Pierre Journal: British journal of haematology Issue: Volume 167:Number 2(2014:Oct.) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher‐risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia. (28th October 2016) Authors: Zeidan, Amer M.; Smith, B. Douglas; Carraway, Hetty E.; Gojo, Ivana; DeZern, Amy; Gore, Steven D. Journal: British journal of haematology Issue: Volume 176:Number 2(2017) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML). (September 2016) Authors: Ravandi, Farhad; Gojo, Ivana; Patnaik, Mrinal M.; Minden, Mark D.; Kantarjian, Hagop; Johnson-Levonas, Amy O.; Fancourt, Craig; Lam, Raymond; Jones, Mary Beth; Knox, Clayton D.; Rose, Shelonitda; Patel, Payal Shah; Tibes, Raoul Journal: Leukemia research Issue: Volume 48(2016:Sep.) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML). (September 2016) Authors: Ravandi, Farhad; Gojo, Ivana; Patnaik, Mrinal M.; Minden, Mark D.; Kantarjian, Hagop; Johnson-Levonas, Amy O.; Fancourt, Craig; Lam, Raymond; Jones, Mary Beth; Knox, Clayton D.; Rose, Shelonitda; Patel, Payal Shah; Tibes, Raoul Journal: Leukemia research Issue: Volume 48(2016:Sep.) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Issue 13 (10th November 2021) Authors: Webster, Jonathan A.; Yogarajah, Meera; Zahurak, Marianna; Symons, Heather; Dezern, Amy E.; Gojo, Ivana; Prince, Gabrielle T.; Morrow, Jillian; Jones, Richard J.; Smith, B. Douglas; Showel, Margaret Journal: Leukemia & lymphoma Issue: Volume 62:Issue 13(2021) Page Start: 3181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia. (September 2022) Authors: Zacholski, Kyle; Hambley, Bryan; Hickey, Erin; Kashanian, Sarah; Li, Andrew; Baer, Maria R; Duong, Vu H; Newman, Matthew J; DeZern, Amy; Gojo, Ivana; Smith, B Douglas; Levis, Mark J; Varadhan, Ravi; Gehrie, Eric; Emadi, Ashkan; Ghiaur, Gabriel Journal: Journal of oncology pharmacy practice Issue: Volume 28:Number 6(2022) Page Start: 1340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗